Arcus Biosciences Inc.
RCUS | NYSE
$26.50
+$0.55 (+2.12%)
Sep 22, 2026, 12:11 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 150M | 201M | 222M | 238M | 248M | 192M | 150M | 201M | 156M | 185M | 127M | 184M | 230M | 238M | 206M | 217.65M | 272.63M | 548.78M | 147.91M | 179.43M | 320.48M | 390.26M |
Short-Term Investments | 552M | 621M | 759M | 593M | 663M | 805M | 828M | 888M | 813M | 810M | 632M | 615M | 700M | 716M | 803M | 831.14M | 900.15M | 664.75M | 351.39M | 345.21M | 400.53M | 436.67M |
Long-Term Investments | n/a | 54M | 29M | 10M | 16M | 8M | 14M | 2M | 40M | 100M | 107M | 160M | 88M | 96M | 134M | 143.14M | 101.33M | 131.84M | 185M | 221.74M | 87.1M | 57.99M |
Other Long-Term Assets | 132M | 61M | 63M | 65M | 69M | 71M | 73M | 75M | 75M | 78M | 106M | 100M | 102M | 107M | 10M | 13.6M | 10.52M | 10.89M | 7.73M | 7.9M | 5.78M | 8.17M |
Receivables | 36M | 7M | 16M | 14M | 20M | 21M | 25M | 21M | 33M | 40M | 42M | 56M | 37M | 36M | 43M | 30.71M | 39.03M | 32.17M | 746.82M | 3.07M | 2.98M | 6.26M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5M | 15M | 10M | 12M | 15M | 13M | 13M | 17M | 20M | 29M | 30M | 26M | 18M | 24M | 14M | n/a | 14.37M | 17.63M | 14.72M | 16.57M | 20.97M | n/a |
Total Current Assets | 756M | 844M | 1.01B | 857M | 946M | 1.03B | 1.02B | 1.13B | 1.02B | 1.06B | 831M | 881M | 985M | 1.01B | 1.07B | 1.1B | 1.23B | 1.26B | 1.26B | 545.29M | 745.95M | 841.87M |
Property-Plant & Equipment | 36M | 38M | 40M | 42M | 44M | 46M | 47M | 48M | 49M | 51M | 51M | 50M | 45M | 37M | 135M | 135.97M | 137.44M | 136.47M | 137.42M | 64.37M | 59.94M | 27.09M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 168M | 153M | 132M | 117M | 129M | 125M | 134M | 125M | 164M | 229M | 264M | 310M | 235M | 240M | 279M | 292.71M | 249.3M | 279.2M | 330.15M | 294M | 152.82M | 93.25M |
Total Assets | 924M | 997M | 1.14B | 974M | 1.08B | 1.16B | 1.15B | 1.25B | 1.19B | 1.29B | 1.1B | 1.19B | 1.22B | 1.25B | 1.35B | 1.39B | 1.48B | 1.54B | 1.59B | 839.29M | 898.77M | 935.12M |
Account Payables | 34M | 39M | 42M | 42M | 29M | 22M | 18M | 13M | 15M | 16M | 17M | 17M | 12M | 28M | 20M | 10.55M | 21.98M | 18.09M | 10.26M | 13.22M | 16.96M | 24.54M |
Deferred Revenue | 19M | 34M | 35M | 52M | 71M | 72M | 85M | 105M | 113M | 124M | 91M | 103M | 103M | 97M | 97M | 103.29M | 90.12M | 89.31M | 102M | 74.34M | 74.57M | 74.57M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9M | n/a | n/a | 3M | n/a | n/a | n/a | 5.1M | n/a | n/a | n/a |
Other Current Liabilities | 12M | 10M | 18M | 16M | 16M | 17M | 14M | 2M | 2M | 1M | 39M | 46M | 48M | 41M | 48M | 45.32M | 38.96M | 39.37M | 30.26M | 41.81M | 30.24M | 25.81M |
Total Current Liabilities | 198M | 209M | 231M | 235M | 210M | 192M | 226M | 215M | 199M | 204M | 184M | 200M | 180M | 179M | 193M | 177.18M | 164.02M | 161.25M | 166.08M | 142.87M | 130.37M | 132.06M |
Long-Term Debt | 101M | 100M | 99M | 98M | 97M | 48M | 48M | 47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 124M | 119M | 135M | 152M | 159M | 166M | 157M | 136M | 138M | 140M | 142M | 145M | 144M | 145M | 23M | 16.17M | 14.68M | 13.87M | 5.26M | 10.2M | 499K | 10.2M |
Total Long-Term Liabilities | 262M | 264M | 277M | 303M | 316M | 433M | 439M | 472M | 352M | 382M | 449M | 471M | 474M | 475M | 495M | 517.95M | 565.36M | 585.59M | 584.36M | 153.82M | 163.85M | 138.27M |
Total Liabilities | 460M | 473M | 508M | 538M | 526M | 625M | 665M | 687M | 551M | 586M | 633M | 671M | 654M | 654M | 688M | 695.12M | 729.39M | 746.85M | 750.45M | 296.68M | 294.22M | 270.33M |
Total Debt | 114M | 113M | 112M | 111M | 109M | 60M | 60M | 58M | 11M | 11M | 11M | 9M | n/a | n/a | 120M | 119.2M | 121.34M | 114.82M | 121.99M | 48.94M | 49.74M | 14.71M |
Book Value | 464M | 524M | 631M | 436M | 549M | 531M | 485M | 565M | 635M | 707M | 462M | 520M | 566M | 600M | 657M | 698.7M | 747.39M | 796.58M | 841.45M | 542.61M | 604.56M | 664.79M |
Book Value Per Share | 3.68 | 4.18 | 5.88 | 4.09 | 5.15 | 5.40 | 5.29 | 6.18 | 6.97 | 8.20 | 6.16 | 6.97 | 7.73 | 8.22 | 9.05 | 9.67 | 10.41 | 11.19 | 11.17 | 7.74 | 8.67 | 9.91 |
Common Stock | 2.17B | 2.14B | 2.12B | 1.82B | 1.79B | 1.78B | 1.62B | 1.6B | 1.58B | 1.56B | 1.31B | 1.29B | 1.27B | 1.23B | 1.21B | 7K | 7K | 7K | 7K | 7K | 7K | 7K |
Retained Earnings | -1.7B | -1.61B | -1.49B | -1.38B | -1.24B | -1.24B | -1.13B | -1.04B | -946M | -853M | -849M | -768M | -697M | -622M | -542M | -474.9M | -409.98M | -343.35M | -275.35M | -554.72M | -476.75M | -400.78M |
Comprehensive Income | -1M | -1M | n/a | n/a | n/a | n/a | n/a | 1M | -1M | -1M | n/a | -3M | -4M | -4M | -7M | -9.8M | -7.24M | -4.66M | -1.26M | -92K | -46K | -2K |
Shareholders Equity | 464M | 524M | 631M | 436M | 549M | 531M | 485M | 565M | 635M | 707M | 462M | 520M | 566M | 600M | 657M | 698.7M | 747.39M | 796.58M | 841.45M | 542.61M | 604.56M | 664.79M |
Total Investments | 552M | 675M | 788M | 603M | 679M | 813M | 842M | 890M | 853M | 910M | 739M | 775M | 788M | 812M | 937M | 974.27M | 1B | 796.59M | 536.39M | 566.95M | 487.63M | 494.65M |
Add to Watchlist
Select watchlists to add or remove RCUS